20105 results for «»
20105 results
Two-year outcomes of transcatheter tricuspid valve edge-to-edge repair for tricuspid regurgitation: The Triluminate pivotal trial
02 Apr 2025
Alex Sticchi interviews Saibal Kar about the two-year results of the Triluminate pivotal trial, unveiled at ACC.25 in Chicago.
After revisiting the one-year findings and outlining the study design, Saibal Kar highlights key takeaways: at two years, TriClip therapy significantly reduced heart failure hospitalisations compared to medical...
Author

Author

Author
Five-year outcomes of the randomised trial of fractional flow reserve guided PCI compared to coronary artery bypass grafting: FAME 3
02 Apr 2025
Kalaivani Mahadevan provides her take on the five-year outcomes of the FAME 3 trial presented by William F. Fearon at ACC.25 in Chicago.

Author
Early intra-aortic balloon pump in heart failure complicated by cardiogenic shock: The Altshock-2 randomized clinical trial
31 Mar 2025
Mirvat Alasnag provides her take on the Altshock-2 randomized clinical trial which was presented by Alice Sacco at ACC.25 in Chicago.

Author
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.

Author
Pi-Cardia reports first commercial cases with ShortCut™
03 Mar 2025
International Women's Day 2025: Raising awareness of aortic stenosis in women: - a silent killer
08 Mar 2025
It was a day in October last year when I had a meeting with patients’ group in UK. At the time, I needed to discuss with them why a registry on valvular heart disease and sex disparities is needed. The camaraderie was incredible and the discussion...

Author
PCR Perspectives in podcast format
26 Feb 2025
Stay at the forefront of interventions for valvular heart disease, coronary, and structural interventions with insights and perspectives
Core Team for PCR Rio Valves 2026
PCR Rio Valves 2026: useful information about the Course
From 2026, PCR Rio Valves is joining forces with TVI by Cardiofy, the conference that’s been gathering cardiac surgeons, interventional cardiologists and imaging specialists in Porto Alegre for the past 4 years.
Our new regional platform aims to foster multidisciplinary interaction for improved decision-making and patient outcomes.
Usefulness of FFR-CT to exclude haemodynamically significant lesions in high-risk NSTE-ACS
07 Mar 2025
This single-arm, double-blinded, core-laboratory adjudicated, prospective trial, conducted across four European centers between August 2019 and April 2022, investigates whether CCTA and FFR-CT are able to exclude hemodynamically significant coronary stenoses in patients with high-risk NSTE-ACS.

Reviewer

Reviewer
Clinical impact of TAVI frame under-expansion and optimisation strategies
07 Mar 2025
Watch this replay with C. Cook, M. Grygier, A. Khokhar and W-K. Kim to learn about the clinical importance of TAVI frame under-expansion, and so much more!
Stent or Leave: considerations for a successful DCB PCI
27 Feb 2025
Watch the replay webinar with F. Ribichini, F. Jafary, Y. Onuma and B. Scheller to learn how to “control” dissections during lesion preparation, and much more!
Pacemaker leads and tricuspid interventions: knowns and unknowns
24 Apr 2025
Watch this webinar with F. Praz, J-C. Deharo, J. Dreyfus and B. Mondésert and learn about the mechanisms and risk of interaction between pacemaker lead and the tricuspid valve, and much more!
Aortic Stenosis in Women: causes, symptoms and treatment options
06 Mar 2025
The patient booklets on this page aim to help women get a better understanding of the condition, recognize symptoms, and explore options to get the right care at the right time.
Introducing our recognised EuroPCR Networkers!
PCR London Valves - What do people think?
PCR Seminars 2025: education brought to your doorstep!
Can’t stand heavy metal: how to treat an ACS with severe metal allergy?
17 Mar 2025

Author
Author

Author
Author
Impact of transcatheter or surgical aortic valve performance on 5-year outcomes in patients at ≥ intermediate risk
12 Mar 2025
The objective of this study was to validate standardised clinical criteria for BVD and evaluate its association with mortality and rehospitalisation, thereby guiding optimal valve selection in clinical practice.

Reviewer